Dr. Rachel Layman is a professor in the department of Breast Medical Oncology at the University of Texas MD Anderson Cancer Center. She received her medical degree and completed her residency in Internal Medicine at Case Western Reserve University in Cleveland, Ohio, and her fellowship in Hematology and Oncology at the University of Michigan in Ann Arbor, Michigan. In addition to treating patients with breast cancer, she is experienced in clinical and translational research. Her areas of interest include hormone receptor positive breast cancer, inflammatory breast cancer, and hereditary breast cancer. She is Director of Clinical Research for the Morgan Welch Inflammatory Breast Cancer Research Program and Clinic and leads the Hormone Receptor Positive Clinical Trials Working Group. She is also Director of Breast Medical Oncology for the MD Anderson Cancer Network.